![PDF) Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology PDF) Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology](https://i1.rgstatic.net/publication/10978748_Evidence-_and_consensus-based_practice_guidelines_for_the_therapy_of_primary_myelodysplastic_syndromes_A_statement_from_the_Italian_Society_of_Hematology/links/0fcfd5111112bee9df000000/largepreview.png)
PDF) Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology
Low-Grade Malignancy Non-Hodgkin's Lymphomas: Prognostic Relevance of their Clinicopathologic Heterogeneity
Impact of Response to Induction Chemotherapy in Patients with Germ Cell Tumors (Gct) Receiving Salvage High-Dose Chemotherapy (H
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Ber
HCMOGT-1 Is a Novel Fusion Partner to PDGFRB in Juvenile Myelomonocytic Leukemia with t(5;17)(q33;p11.2)
![La ricerca ha bisogno del tuo aiuto. Dona il tuo 5X1000 al San Matteo - Policlinico San Matteo Pavia Fondazione IRCCS La ricerca ha bisogno del tuo aiuto. Dona il tuo 5X1000 al San Matteo - Policlinico San Matteo Pavia Fondazione IRCCS](http://www.sanmatteo.org/contents/instance1/files/photo/1248_30_sito_melaz2.jpg)